The EPICUP® test is a new tool that helps identify up to 87% of cases of cancer of unknown origin (CUP) Article Esteller M The Lancet Oncology
The first epigenetic test to identify tumors of unknown primary Read More »
Scientists find that colorectal tumors present epigenetic heterogeneity relates to the clinical course of the disease. Article citation Esteller M Gastroenterology
Not all tumor cells are equal Read More »
With this initiative, the BBVA Foundation promotes individual effort for the collective benefit of professionals in an intermediate stage of his career and who have demonstrated high productivity and innovativeness the BBVA Foundation has awarded one of the Grants for Researchers and Cultural Creators
The oncologists Manel Esteller, Joan Massagué and Josep Baselga are the winners of the 28th Catalunya International Prize “for his revolutionary task, especially on oncology research, with what they significantly contributed to the advances of global medicine”. The awards, recently announced by the President of the Generalitat de Catalunya (Catalan Government), Carles Puigdemont, are given
Dr Jordi Carratalà, IDIBELL researcher, is a member of the international panel that created these new guidelines published by the Infectious Diseases Society of America and the American Thoracic Society.
ACCIÓ Investment Forum presentation of Tractivus main meeting points between entrepreneurs and investors in Catalonia Joan Gilabert, CEO of Tractivus, presented in a one-minute-long elevator pitch their design project of 3D-printed custom and antibacterial medical devices 3rd runner-up 400 networking meetings IDIBELL had an active participation, introducing the projects that make up its portfolio of proposals for innovation and technology transfer Alon Lifshitz companies and investors from Israel Enterprise Catalog 2016 top 50 business projects
Tractivus, ACCIÓ Investment Forum Award finalist Read More »
IDIBELL has endorsed the document of recommendations for finding solutions in the field of rare diseases by AELMHU and FEDER, and the Rett Syndrome awareness campaign “El Retto” document of recommendations for finding solutions in the field of rare diseases quality of life three million measures knowledge research and equitable access financing and price IDIBELL has also initiated a partnership with the web “The Retto” to explain and raise awareness of Rett syndrome Manel Esteller Sònia Guil
IDIBELL, supporting rare disease research Read More »
Researchers from the Institute of Biomedical Investigation of Bellvitge (IDIBELL) have demonstrated that selective inactivation of the p110α PI3K isoform is sufficient to block tumor progression and metastasis in a mice model of PanNETs.
The PI3K protein: a potential new therapeutic target in pancreatic neuroendocrine tumors Read More »
Talking to the staff, the conseller made clear that “you are the key to success”
La presidenta del Parlament i el conseller de Salut visiten l’hospital Read More »
